A Study on the Preference of Risperidone Dosage Forms

Shanghai Mental Health Center1,000 enrolled

Overview

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

This study aims to understand patients' needs and preferences for antipsychotic dosage forms and to clarify the clinical value of patch-form antipsychotics.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Schizophrenia Bipolar Affective Disorder Autism Spectrum Disorder Conduct Disorder Mental Retardation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study. Exclusion Criteria: * Have difficulty reading and understanding Chinese or refuse to participate in the study.

Locations (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China

RECRUITING

Outcomes

Primary Outcomes

Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine

The proportion of patients (and their caregivers) who preferred risperidone patch among the respondents in this study

Time frame: "through study completion, an average of 6 months

Secondary Outcomes

Factors related to patients' preference for risperidone patch-form medicines

Patients' evaluation of the importance of each advantage of risperidone patch in a self-made questionnaire (5-point Likert scale score)

Time frame: through study completion, an average of 6 months

Central Contacts

Lan Luo, Doctor of Medicine

CONTACT

+8618516544150 lan-luo@foxmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.